We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$1.94B
AUM Growth
-$23.6M
Cap. Flow
-$64.7M
Cap. Flow %
-3.33%
Top 10 Hldgs %
21.65%
Holding
135
New
8
Increased
29
Reduced
90
Closed
8

Top Sells

Rank Stock Value
1
AZEK
The AZEK Co
AZEK
+$38.7M
2
DY icon
Dycom Industries
DY
+$23.3M
3
SUPN icon
Supernus Pharmaceuticals
SUPN
+$20.3M
4
TKO icon
TKO Group
TKO
+$17.9M
5
ITRI icon
Itron
ITRI
+$15.7M

Sector Composition

Rank Sector Weight
1 Industrials 22.9%
2 Technology 20.69%
3 Financials 15.7%
4 Healthcare 13.43%
5 Consumer Discretionary 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HXL icon
51
Hexcel
HXL
$7.73B
$16.4M 0.84%
261,406
-784
-0.3% -$48.1K
UCB
52
United Community Banks
UCB
$4.29B
$16.4M 0.84%
521,654
-8,736
-2% -$276K
BANR icon
53
Banner Corp
BANR
$2.4B
$15.8M 0.81%
240,709
-4,261
-2% -$280K
RRC icon
54
Range Resources
RRC
$9.43B
$15.3M 0.79%
405,436
+271,304
+202% +$9.69M
SONO icon
55
Sonos
SONO
$1.87B
$15.1M 0.78%
957,633
-14,659
-2% -$188K
MATW icon
56
Matthews International
MATW
$876M
$15M 0.77%
617,504
-10,814
-2% -$265K
CRL icon
57
Charles River Laboratories
CRL
$11.1B
$14.9M 0.77%
95,348
-1,003
-1% -$159K
NOVT icon
58
Novanta
NOVT
$5.28B
$14.9M 0.77%
148,885
+26,229
+21% +$3.12M
SLRC icon
59
SLR Investment Corp
SLRC
$709M
$14.7M 0.76%
962,006
-18,405
-2% -$299K
SUPN icon
60
Supernus Pharmaceuticals
SUPN
$2.67B
$14.6M 0.75%
305,273
-503,122
-62% -$20.3M
WWW icon
61
Wolverine World Wide
WWW
$1.62B
$14.6M 0.75%
530,570
-309,282
-37% -$8.14M
UTL icon
62
Unitil
UTL
$963M
$14.4M 0.74%
300,589
+5,332
+2% +$260K
AXTA icon
63
Axalta
AXTA
$7.76B
$14.1M 0.73%
491,821
-7,129
-1% -$215K
JHX icon
64
James Hardie Industries
JHX
$16.1B
$14M 0.72%
+729,798
New +$17.5M
BHE icon
65
Benchmark Electronics
BHE
$2.91B
$13.4M 0.69%
348,482
-2,622
-0.7% -$104K
ASC icon
66
Ardmore Shipping
ASC
$712M
$13.3M 0.68%
1,116,378
-15,896
-1% -$178K
TCBI icon
67
Texas Capital Bancshares
TCBI
$4.4B
$12.9M 0.66%
152,356
-2,662
-2% -$227K
JJSF icon
68
J&J Snack Foods
JJSF
$1.48B
$12.6M 0.65%
131,108
-2,389
-2% -$265K
NSIT icon
69
Insight Enterprises
NSIT
$3.98B
$12.5M 0.65%
110,551
-1,333
-1% -$173K
DLB icon
70
Dolby
DLB
$5.59B
$12.4M 0.64%
171,358
+160,278
+1,447% +$11.8M
ONB icon
71
Old National Bancorp
ONB
$10.3B
$12M 0.62%
545,149
-10,718
-2% -$237K
KNX icon
72
Knight Transportation
KNX
$11.1B
$11.9M 0.61%
301,450
+242,573
+412% +$10.5M
PRGO icon
73
Perrigo
PRGO
$1.48B
$11.3M 0.58%
507,106
+106,905
+27% +$2.61M
QDEL icon
74
QuidelOrtho
QDEL
$1.21B
$11.3M 0.58%
382,389
+146,956
+62% +$4.02M
HGV icon
75
Hilton Grand Vacations
HGV
$3.52B
$10.5M 0.54%
+251,707
New +$11.6M

Similar funds

Aristotle Capital Boston's Q3 2025 Portfolio in Review

As of Q3 2025, Aristotle Capital Boston held 135 positions worth $1.94B, down 1.2% from $1.96B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aristotle Capital Boston withdrew a net $64.7M in Q3 2025, closing 8 positions and reducing 90 holdings. Its most notable exit was The AZEK Co, an estimated $38.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Aristotle Capital Boston opened a new position in James Hardie Industries worth $14M.

  • Aristotle Capital Boston's largest Q3 2025 buy was James Hardie Industries: 729,798 shares worth $14M.
  • Aristotle Capital Boston added most to Dolby in Q3 2025, an estimated $11.8M increase.
  • Aristotle Capital Boston's biggest Q3 2025 reduction was Dycom Industries, cutting an estimated $23.3M.
  • Aristotle Capital Boston fully exited The AZEK Co in Q3 2025, selling an estimated $38.7M.
  • Aristotle Capital Boston's ten largest holdings make up 22% of its $1.94B portfolio in Q3 2025.
  • Aristotle Capital Boston opened 8 new positions and closed 8 in Q3 2025.
  • Aristotle Capital Boston's portfolio value fell 1.2% quarter-over-quarter to $1.94B.

Based on Aristotle Capital Boston's 13F filing for Q3 2025, filed 14 Nov 2025.